The goal of this project is to rapidly screen promising agents, in the setting of an adaptive platform trial, for treatment of critically ill COVID-19 patients. In this phase 2 platform design, agents will be identified with a signal suggesting a big impact on reducing mortality and the need for, as well as duration, of mechanical ventilation.
COVID-19
The goal of this project is to rapidly screen promising agents, in the setting of an adaptive platform trial, for treatment of critically ill COVID-19 patients. In this phase 2 platform design, agents will be identified with a signal suggesting a big impact on reducing mortality and the need for, as well as duration, of mechanical ventilation.
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
-
University of Alabama at Birmingham, Birmingham, Alabama, United States, 35294
UC Davis Medical Center, Davis, California, United States, 95817
UC Irvine Medical Center, Irvine, California, United States, 92868
Long Beach Memorial Medical Center, Long Beach, California, United States, 90806
Kaiser LAMC, Los Angeles, California, United States, 90027
University of Southern California, Los Angeles, California, United States, 90033
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States, 92663
University of California San Francisco (UCSF), San Francisco, California, United States, 94115
University of Colorado, Aurora, Colorado, United States, 80045
Yale Cancer Center, New Haven, Connecticut, United States, 06510
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
QuantumLeap Healthcare Collaborative,
Carolyn Carolyn, MD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco
Kathleen D Liu, MD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco
Laura Esserman, MD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco
2030-07-31